Bioethics News

Theranos Gives Up on Blood-Testing Labs to Become the Thing It Tried to Fix

(Wired) – Theranos was once among the most exciting startups in Silicon Valley. It got that way by telling everyone a story: Its technology was an alternative to the price tags, big needles, and gate-keeping doctors of traditional blood testing. Today, nearly a year after Wall Street Journal reporter John Carreyrou published the first of many investigative articles into the company’s struggles and lies, Theranos is changing its story.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.